Author:
Fell D.B.,Dimanligh-Crez S.,Regan A.K.,Haberg S.E.,Christopher A.G.,Oakley L.,Alton G.D.,Torok E.,Dhinsa T.,Shah P.S.,Wilson K,Sprague A.E.,El-Chaar D.,Walker M.C.,Barrett J.,Okun N.,Buchan S.A.,Kwong J.C.,Wilson S.E.,Dunn S.I.,MacDonald S.E.,Dougan S.D.
Abstract
(BMJ. 2022;378:e071416)
COVID-19 infection during pregnancy increases the risk of preterm birth, fetal growth restriction, postpartum hemorrhage, and stillbirth pregnancies. In addition, women of reproductive age also remain among the lowest to seek the SARS-CoV-2 vaccine since Canada’s introduction of vaccines on December 14, 2020, possibly due to pregnancy risk claims. This study retrospectively researched preterm births, small for gestational age (SGA) births, and stillbirths and the COVID-19 vaccine.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science